David Shaw’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-811
Closed -$251K 4542
2023
Q2
$251K Hold
811
﹤0.01% 3665
2023
Q1
$247K Hold
811
﹤0.01% 3820
2022
Q4
$241K Hold
811
﹤0.01% 4174
2022
Q3
$236K Hold
811
﹤0.01% 4404
2022
Q2
$236K Hold
811
﹤0.01% 4475
2022
Q1
$237K Hold
811
﹤0.01% 4770
2021
Q4
$235K Buy
+811
New +$236K ﹤0.01% 4801

Other funds holding XAGE

David Shaw's XAGE Position: Q3 2023 in Review

David Shaw sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 811 shares — an estimated $251K sold.

David Shaw first reported a position in XAGE in Q4 2021 and held it in 7 quarters. The position peaked at $251K in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • David Shaw reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • David Shaw sold 811 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $251K.
  • David Shaw first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • David Shaw's Longevity Health Holdings, Inc. Common Stock position peaked at $251K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.